We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

AACC 2020 Disruptive Tech Award-Winning Diagnostic Testing Platform Could Detect COVID-19 in 14 Minutes

By HospiMedica International staff writers
Posted on 17 Dec 2020
Print article
Image: FINDER (Photo courtesy of Baebies)
Image: FINDER (Photo courtesy of Baebies)
A COVID-19 test is being developed on a near-patient testing platform that won the Disruptive Technology Award at the 2020 AACC virtual meeting and could perform rapid reverse transcription polymerase chain reaction (RT-PCR) to generate results in as little as 14 minutes.

The AACC's Disruptive Technology Award recognizes innovative technologies for diagnostic testing that can improve patient care. The Finder diagnostic testing platform from Baebies (Durham, NC, USA) is designed specifically for infants and requires a smaller blood sample. The CE-Marked platform includes an instrument and a cartridge, which tests for Glucose-6-Phosphate Dehydrogenase (G6PD) from low blood volume, a single drop of whole blood (50 μL), with a turn-around time of approximately 15 minutes after sample introduction.

FINDER uses digital microfluidics (DMF), a method to programmably manipulate separate droplets of liquid by electrical control of surface tension, or electrowetting, to perform bioassay protocols. DMF enables quick precision handling of discrete droplets on FINDER’s disposable cartridge - which is completely self-contained with all reagents on board. DMF supports multifunctional assay methods - including molecular, immunoassay, and chemistry - on the same cartridge. FINDER has a small footprint at just eight inches wide along with a tablet for user interface.

FINDER has a robust test development pipeline. Due to the current need for rapid diagnostics for SARS-CoV-2, a test for the detection of COVID-19 is being developed on FINDER 1.5 to perform rapid RT-PCR to generate results in as little as 14 minutes.

“Every test is a chance to save a life,” said Vamsee Pamula, PhD, co-founder and President of Baebies. “While we will continue to give babies a healthy start in newborn screening with FDA-authorized SEEKER, we can now expand to save even more lives with FINDER.”

Related Links:
Baebies

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Autoclavable Camera System
Precision AC

Print article

Channels

Critical Care

view channel
Image: A demonstration of the on-skin wearable bioelectronic device (Photo courtesy of University of Missouri)

On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants

A team of researchers at the University of Missouri (Columbia, MO, USA) has achieved a milestone in developing a state-of-the-art on-skin wearable bioelectronic device. This development comes from a lab... Read more

Surgical Techniques

view channel
Image: The hyperspectral imaging system extracts molecular vibrations of different resins and distinguishes between them with high reproducibility (Photo courtesy of Hiroshi Takemura from Tokyo University of Science)

Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery

Hyperspectral imaging (HSI) is an advanced technique that captures and processes information across a given electromagnetic spectrum. Near-infrared hyperspectral imaging (NIR-HSI) has particularly gained... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more